{"name":"Vantive Health LLC","slug":"vantive-health-llc","ticker":"","exchange":"","domain":"vantivehealthllc.com","description":"Vantive Health LLC is a specialized pharmaceutical company focused on developing and marketing innovative peritoneal dialysis solutions for patients with kidney disease. The company has a portfolio of marketed products and a robust pipeline in late-stage clinical development, positioning it as a leader in renal therapy.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"oncology","drugs":[{"name":"Dianeal","genericName":"Dianeal","slug":"dianeal","indication":"Other","status":"marketed"},{"name":"Nutrineal","genericName":"Nutrineal","slug":"nutrineal","indication":"Other","status":"marketed"},{"name":"Biphozyl","genericName":"Biphozyl","slug":"biphozyl","indication":"Other","status":"phase_2"},{"name":"Dianeal, Extraneal, Nutrineal","genericName":"Dianeal, Extraneal, Nutrineal","slug":"dianeal-extraneal-nutrineal","indication":"End-stage renal disease requiring peritoneal dialysis","status":"phase_3"},{"name":"Experimental Peritoneal Dialysis Solution","genericName":"Experimental Peritoneal Dialysis Solution","slug":"experimental-peritoneal-dialysis-solution","indication":"End-stage renal disease requiring peritoneal dialysis","status":"phase_3"},{"name":"Extraneal","genericName":"Extraneal","slug":"extraneal","indication":"Other","status":"marketed"},{"name":"Regiocit","genericName":"Regiocit","slug":"regiocit","indication":"Other","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Prismocitrate 18","genericName":"Prismocitrate 18","slug":"prismocitrate-18","indication":"Regional citrate anticoagulation for continuous renal replacement therapy (CRRT) in critically ill patients","status":"phase_3"}]}],"pipeline":[{"name":"Dianeal","genericName":"Dianeal","slug":"dianeal","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nutrineal","genericName":"Nutrineal","slug":"nutrineal","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Biphozyl","genericName":"Biphozyl","slug":"biphozyl","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dianeal, Extraneal, Nutrineal","genericName":"Dianeal, Extraneal, Nutrineal","slug":"dianeal-extraneal-nutrineal","phase":"phase_3","mechanism":"These are peritoneal dialysis solutions that facilitate fluid and solute exchange across the peritoneal membrane to remove waste products and excess water from the blood in patients with kidney failure.","indications":["End-stage renal disease requiring peritoneal dialysis","Chronic kidney disease Stage 5 managed via peritoneal dialysis"],"catalyst":""},{"name":"Experimental Peritoneal Dialysis Solution","genericName":"Experimental Peritoneal Dialysis Solution","slug":"experimental-peritoneal-dialysis-solution","phase":"phase_3","mechanism":"An experimental peritoneal dialysis solution designed to improve solute clearance and fluid removal in patients with end-stage renal disease undergoing peritoneal dialysis.","indications":["End-stage renal disease requiring peritoneal dialysis"],"catalyst":""},{"name":"Extraneal","genericName":"Extraneal","slug":"extraneal","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Prismocitrate 18","genericName":"Prismocitrate 18","slug":"prismocitrate-18","phase":"phase_3","mechanism":"Prismocitrate 18 is a citrate-based anticoagulant used in regional citrate anticoagulation (RCA) for extracorporeal therapies.","indications":["Regional citrate anticoagulation for continuous renal replacement therapy (CRRT) in critically ill patients","Anticoagulation for extracorporeal blood purification therapies"],"catalyst":""},{"name":"Regiocit","genericName":"Regiocit","slug":"regiocit","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOVG5QUm0xSGVfYnN5bU9fVk4xczl6ZVVIS2tRLXhCYkdJUVBCQ2hIUHVjdTc4NVZFYjljVGJSZUpWR2dYMkdjMERDVF9XLWIzaHpMdkxMWnV1QnFVRmlXSDVUaTBYcVJPak9rYURhTFltM21hN2ZKMVQ5TklpODJzaDd0ZDJoaFl0LV8wU3MtU3lXWVJvNlFKYlFtdEgyeEV6OThqd0ZjSG9Wc2xZZ1E?oc=5","date":"2026-01-29","type":"pipeline","source":"Bloomberg Government News","summary":"Big Ballroom Donation Divulged by Health Care Company Vantive - Bloomberg Government News","headline":"Big Ballroom Donation Divulged by Health Care Company Vantive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOYjZKdzJlZmsxZi14UnNSaGU5STdISF9mZjIyTkdkUk5UemxLbkxrcFp6Sjg4ZzJCNlA1eHNsdmhpclptNXMwMWd2NHRKU2VNaG5ENEhLRW9UdWNsZmhuVUFGQWt0dk82TkVwVUJtWHVSMVFWR3h2WjcyejEtRXcxcjNzSU9MWTRvWEhSUVhtc1dlUEFNU1ZKNVNqTmhkSFlETDZj?oc=5","date":"2025-10-03","type":"pipeline","source":"codeblue.galencentre.org","summary":"‘We Can’t Keep Building New Dialysis Centres’: Health Deputy DG - codeblue.galencentre.org","headline":"‘We Can’t Keep Building New Dialysis Centres’: Health Deputy DG","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQaXQwS2tFM1dKX3p2OW55ZlVFY1VqRjBMVjNBVEdfRzZ4WEhweExhdDY0VGtaTVducDFkbXhsVHgtRHdPRnpGQVFwanlxT1RrcnR0QU8yeXN2VWRNTl9TUmUwanNDR0hxZHB1amJGYjc5SF9kVmc0SFkwNllRQ3JBdGU3aWFtb0Z0U041QTRpTVMya2N1bGFhVFlsVWt1YzFYdHVRaGFQVXA1ZGV1aVNVVExfaUxrbF9DOGRVVFRMeFNMU0lZNFc3Z0ZwWEZ3U3NUMklIcDVaMEtMbVZaaFZVNk9CeTZDRkgtVGRla1o2Nmd6N2JuZzhTeDJQaTBZZFFvVGQxVkdQUUVVZkFmMnotajBBRXBKU2ZzTnNFcnF2WjJqaGJaZUZwYm9acERuVEVaRUFBWnpWVEF5NEZ1SGVlYw?oc=5","date":"2025-08-12","type":"pipeline","source":"GlobeNewswire","summary":"Spectral Medical and Vantive Announce Topline Results from - GlobeNewswire","headline":"Spectral Medical and Vantive Announce Topline Results from","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxOa1F4aVZmY3B6V0k0SUNJdDMtbnRxcEJEbTVMNHEtclJoZWR3NFlkOHIwa25zbHFjbUVPaTI4ZkVpRTJjalBhS3lhUkFPZnhEZElkbHA2ZklrRDVtbldCZlpvdDRZM0xGbWEwWXdjc0xET2tlSmJ1N0xQZWljYkxkUUdwZmJ4ZG50VUI0WU1kZklpVWxDWWdLQkpTSWRuLWVtNjc1cUJUS056c1JsWnJRQUNLME5vbUkwRmw2dXdmRkFSWDJSMWlJOElQODVUbzNfcm00bE1OUnpsRkVDbHRkZEp6a3FUUGJDY3JHUDBac0ZDeWxpZ1ViVHFxODlrZlZXLWVmQ3k1eEczR2c2QVN2YWhNQjZlZ3FidW5naTJpWGlhTmZ3Uk9uVDh1eERWZFEtQTcyeg?oc=5","date":"2025-07-16","type":"pipeline","source":"GlobeNewswire","summary":"Vantive and Innovative Renal Care Enter into a Long-Term - GlobeNewswire","headline":"Vantive and Innovative Renal Care Enter into a Long-Term","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOcTduR3JBaEZISThQaDdjOFQwR3VGUXYtanIzUF8wQmVLNU5mWVBqbjlycmktUENfaU1LMlphRUUzVEhadFlwSzQtc21xMDEwbU9oSmxhd25TM2p5WjJxbnF2bjduOWZzUGdjUkxxMEZFRjVmeDMwRGhrNkkzc1RQQ2drdjRNdw?oc=5","date":"2025-06-08","type":"pipeline","source":"OpenSecrets","summary":"Dept of Health & Human Services Lobbying Profile - OpenSecrets","headline":"Dept of Health & Human Services Lobbying Profile","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQNDFUTlZjdmdIdmRZamdxckhpM0Itc1NRelNsdENqNzM0aU5rVzhuUlNmbDhDTnBTQ3U0bkQtNVVBWDUtZEN0cW1EbjliQ0NrV0U5ekdFbFROQU1xSDVhQ1h1eENVVHZBYXFJcjlRTmJjX0swcVVOaVJLbDZCajhtRWVhTkFWaXdZZ0o4RmNzOVgtajNsWTFJeHJyQmNJUQ?oc=5","date":"2025-06-03","type":"pipeline","source":"BioWorld News","summary":"Vantive to invest $1B in digital kidney support therapies - BioWorld News","headline":"Vantive to invest $1B in digital kidney support therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQUGtMOXI0S1BPYVpqbXJsbzRpaTg3WFluZmIxbmhlMDdycE5kbDJEaHBhemxYRUl5aUFXa2F2VmlhNld5UFUzUnZTeU9yMDVfazRiel9Ray1iajJFQjRLNjJjT0Z1RVNqRmo2MnBVOUpnSjFETDNqN0VlckdFbUhfZVMzQVNNNkRhazR0eHM3dkZuY3FTNU0xeXNnR1c4Q2Fyc1dOUkN3Q01TYWlxdnBSYkp1V3NtajR6elNKYkZBbTN4OEtHeXFTRFVXaE5HeVhaV3Q2QjZodEV0YWRwZnBpMThNOHZoS1JhX3h3S0xaUVo1enU3WEItX3pBbmNJRzFKTTNOWVNqLUpQS0VsUkhHLW81M0lybzg0U0lhZ2ZkQQ?oc=5","date":"2025-06-02","type":"pipeline","source":"GlobeNewswire","summary":"Vantive to Invest More Than $1 Billion in Advancing Kidney - GlobeNewswire","headline":"Vantive to Invest More Than $1 Billion in Advancing Kidney","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBhYk9IYkpBSjJ1dmVXRDVzMWRCcUdXSFk3SGY5ZDZWLWJuRVdsVE5LS0dFbXdLREtybmFaM1l4aUNqZlBtREIxSF94SWxWZkR4S25HbUt2VVB2dWVXVG9hZ0tMT0NVSVpCOU1Bb2Q3MUlOSGhzV2RCd3d4c01fUQ?oc=5","date":"2025-06-02","type":"pipeline","source":"MassDevice","summary":"Former Baxter kidney unit Vantive to invest $1B in digitally enabled therapies - MassDevice","headline":"Former Baxter kidney unit Vantive to invest $1B in digitally enabled therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQNkYwNXlJanNJY1NZRURpSFFIMFhCcHotQWt5cnJ1MGcwQjR1SUlmRXZ5LWM1TnQ2Q3VKQ01IZGE3X3Rub3F1T0dZVTBBU0Q4MTNiMmYzTVJqQUJBQkxfQUUyQmVjY1AxSGs0Y1BmM2F4ZU5qYjB4ZkZGWUlZY1J1RjllSk9wUVBTYTAzdDh1aDVadUdTMFc1Wi1RVk1kbVh3V1lORXZMRnc0cHJ3SEhENm02cmlGSjViUEI1VjRRWU4xdGsyUFo3ektsMXdtYmZtSV93dFZR?oc=5","date":"2025-04-25","type":"earnings","source":"Chicago Tribune","summary":"Kidney care company spun off from Baxter earlier this year establishes headquarters in Deerfield - Chicago Tribune","headline":"Kidney care company spun off from Baxter earlier this year establishes headquarters in Deerfield","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQeTRGVml4T05tSzE5XzBldHp2WnRza1VrTXdtbzBJRWVfV1hSa1ZBeWdWcDNIdEtJY0RMQjZSQWYyb1ZSbmU2YTE4R1g5VjlQZlhMdGtyZHZ0U0lSbll5ZF9UdG1Ic25aSzJMXy1LZE5ydU0yRlJURkNzcU5YY1E4RDdmcTZoeXEyR29hc25VbUJxT1A4WGVYeS1Kbzc1cjB6bmUxTVAtd2xaRHlWc1FlSFRObw?oc=5","date":"2024-08-19","type":"pipeline","source":"Forbes","summary":"Baxter To Sell Its Kidney Care Unit To Carlyle For $3.8 Billion - Forbes","headline":"Baxter To Sell Its Kidney Care Unit To Carlyle For $3.8 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNcnBmWlpGSTgxVENzWEp0OE1Vc0JDNVZybC1HWnRxdDhHSTZFY00xT09feG5La1ZCRmZKZTNkbDZhci1OWmZ0NlFMeDM2UkU2RkVOQ3RuWFd1MFJ4cFdVZ2J3MWhGQ0ZwUVBidkplN2Y1OTgzWGx6VzhsbE5tRFVDQ2hkZEtqM1lhNlFDdXFzVGUtV3d3YkJCUFlDZy1jdHlfNlFFU0R4WV85cU1SZnNXenJ4Z2JGbldPRHVUQzFjWWdzWjZuaDF1bk9B?oc=5","date":"2024-08-13","type":"deal","source":"Reuters","summary":"Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion - Reuters","headline":"Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPT3RObEUxcEFlbVprOFFZMmR3SERscFNmTWpqb2lzczU1cW1vLTN2MzltbmZTbmlkYi12TmkzVXA1NzRxSkxiZXBoMjk4VjMwaGctN1loeUZ0TFR3R0xWQXRuUVQ5Wm9FaHRDVUlkd2dVS0VtMDFYXzJEejhEbVBTSjZycHlZT29CQXVXWndraXRZbnQwYnNubXN0dzdGOUZ6elM5cF91OEdzbXdzNTJYcno0OTl0SDlVb0pB?oc=5","date":"2024-08-13","type":"pipeline","source":"Fierce Biotech","summary":"To pay down debt, Baxter sells its $4.5B Vantive kidney care division to the Carlyle Group for $3.8B - Fierce Biotech","headline":"To pay down debt, Baxter sells its $4.5B Vantive kidney care division to the Carlyle Group for $3.8B","sentiment":"neutral"}],"patents":[],"drugCount":8,"phaseCounts":{"marketed":3,"phase_2":2,"phase_3":3},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}